- Orica’s net income increased to A$524.6 million, up 77% compared to the previous year.
- The net profit after tax (NPAT) before significant items reached A$409.4 million, marking an 11% increase year-over-year.
- The company declared a final dividend of A$0.28 per share.
- Sales revenue for Orica was A$7.66 billion, which is a decrease of 3.6% from the previous year.
- Capital expenditure totaled A$456 million.
- Analyst recommendations included 10 buys, 4 holds, and no sells.
A look at Orica Ltd Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Orica Ltd, a diversified manufacturing company, has received a mix of Smart Scores indicating its long-term outlook. With high scores in Growth and Value, the company seems well-positioned for future expansion and is considered reasonably valued. However, lower scores in Dividend and Resilience suggest potential weaknesses in these areas. Momentum is also moderate, indicating stable but not extraordinary performance. Overall, Orica Ltd‘s outlook appears positive due to its strong indicators in Growth, while areas like Dividend and Resilience may need attention to improve overall stability.
Orica Ltd operates in various sectors, including industrial and specialty chemicals, surface coatings, and explosives for mining and construction industries. Despite some challenges in dividend payouts and resilience, the company’s focus on growth and value generation could drive long-term success. Investors may find Orica Ltd an attractive option for capital appreciation and potential expansion opportunities, considering its robust Growth score and diversified product portfolio.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
